Skip to main content
. 2018 Jul 25;156:800–814. doi: 10.1016/j.ejmech.2018.07.032

Table 3.

In vitro antitumor activities of compounds 3a-3c.

Compd. Position IC50(μM)
K562 HepG2
CPT 0.07 ± 0.01 0.37 ± 0.06
2m 5 0.03 ± 0.01 0.05 ± 0.03
3a 4 >10 >10
3b 6 7.46 ± 1.69 >10
3c 7 4.43 ± 0.75 8.56 ± 0.06

3.